Ms. Kearney will be responsible for overall Study Operations of the NeuroNEXT Clinical Coordination Center, ensuring that all aspects of the planned clinical trials are conducted in full compliance with DHHS, NIH, NINDS and FDA policies and regulations. She will play a role in developing a training module on Good Clinical Practice (GCP) as well as other topics to ensure all sites have an adequate knowledge and understanding of their roles and responsibilities. Marianne has been involved in a variety of roles in the conduct of multi-center clinical trials for over 20 years with a focus in project management, regulatory affairs, site monitoring and compliance and site management, and has worked in both academia and industry. She is fully committed to this NINDS initiative, and will be an active member of the NEXT-CCC Leadership Team at MGH, collaborate with the NEXT-Clinical Sites, the NEC and DCC to ensure that all trials are conducted with the highest quality and managed efficiently.